Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T79116 | JAK-IN-28 | JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
JAK-IN-28(Compound 111)为一JAK抑制剂,适用于癌症及炎症性疾病研究领域。 | |||
T78175 |
JAK-IN-25
|
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
JAK-IN-25(化合物19)是一种高效的JAK抑制剂,对TYK2、JAK1、JAK2和JAK3的IC50值分别为6 nM、21 nM、8 nM、1051 nM。该化合物还能抑制人全血中IL-12(HEB IL-12),IC50为28 nM,显示其在癌症研究中的潜在应用价值。 | |||
T68306 |
INCB16562
|
||
INCB16562 is a novel, selective, and orally bioavailable small-molecule inhibitor of JAK1 and JAK2 markedly selective over JAK3. Treatment of myeloma cells with INCB16562 potently inhibited interleukin-6 (IL-6)-induced phosphorylation of STAT3. INCB16562 abrogated the protective effects of recombinant cytokines or bone marrow stromal cells and sensitized myeloma cells to cell death by exposure to dexamethasone, melphalan, or bortezomib. Oral administration of INCB16562 antagonized the growth of ... |